Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major

Leishmaniasis is the 3rd most challenging vector-borne disease after malaria and lymphatic filariasis. Currently, no vaccine candidate is approved or marketed against leishmaniasis due to difficulties in eliciting broad immune responses when using sub-unit vaccines. The aim of this work was the desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayari-Riabi, Sana, Ben khalaf, Noureddine, Bouhaouala-Zahar, Balkiss, Verrier, Bernard, Trimaille, Thomas, Benlasfar, Zakaria, Chenik, Mehdi, Elayeb, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783570/
https://www.ncbi.nlm.nih.gov/pubmed/36557812
http://dx.doi.org/10.3390/molecules27248677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783570/
https://www.ncbi.nlm.nih.gov/pubmed/36557812
http://dx.doi.org/10.3390/molecules27248677

Ejemplares similares